Recent work developed a novel, biomimetic, cost effective 3D hollow fibre bioreactor for growing healthy red blood cells ex vivo [4]. This bioreactor recapitulates the architectural and functional properties of erythrocyte formation and thereby reduces the need for expensive growth factors by more than an order of magnitude. But the optimal bioreactor design is unclear; we propose global, robust, superstructure optimisation for configuring and operating the bioreactor. We discuss the potential of robust superstructure design not only on this individual bioreactor but also more generally on bioprocess optimisation..
AbstractTissue engineering aims to repair and regenerate damaged tissues by developing biological su...
Tissue vasculature efficiently distributes nutrients, removes metabolites, and possesses selective c...
The short shelf life along with the constant threat or an actual shortage of red blood cells (RBCs) ...
Recent work developed a novel, biomimetic, cost effective 3D hollow fibre bioreactor for growing hea...
As breakthrough cellular therapy discoveries are translated into reliable, commercializable applicat...
Successful ex vivo production of RBCs from human umbilical cord blood (hUCB) for transfusion would r...
Blood shortage is one of the biggest concerns of the World Health Organization. The reason: while ar...
The feasibility of ex vivo blood production is limited by both biological and engineering challenges...
We present an overview of the key building blocks of a design framework for modeling and optimizatio...
Human red blood cell production, or erythropoiesis, occurs within bone marrow. Living animal and hum...
One of the World Health Organization’s biggest concerns is meeting blood demand while ensuring safet...
Cellular microenvironments provide stimuli including paracrine and autocrine growth factors and phys...
Radial flow perfusion of cell-seeded hollow cylindrical porous scaffolds may overcome the transport ...
In this paper, we discuss the basic design requirements for the development of physiologically mean...
Generating autologous tissue grafts of a clinically useful volume requires efficient and controlled ...
AbstractTissue engineering aims to repair and regenerate damaged tissues by developing biological su...
Tissue vasculature efficiently distributes nutrients, removes metabolites, and possesses selective c...
The short shelf life along with the constant threat or an actual shortage of red blood cells (RBCs) ...
Recent work developed a novel, biomimetic, cost effective 3D hollow fibre bioreactor for growing hea...
As breakthrough cellular therapy discoveries are translated into reliable, commercializable applicat...
Successful ex vivo production of RBCs from human umbilical cord blood (hUCB) for transfusion would r...
Blood shortage is one of the biggest concerns of the World Health Organization. The reason: while ar...
The feasibility of ex vivo blood production is limited by both biological and engineering challenges...
We present an overview of the key building blocks of a design framework for modeling and optimizatio...
Human red blood cell production, or erythropoiesis, occurs within bone marrow. Living animal and hum...
One of the World Health Organization’s biggest concerns is meeting blood demand while ensuring safet...
Cellular microenvironments provide stimuli including paracrine and autocrine growth factors and phys...
Radial flow perfusion of cell-seeded hollow cylindrical porous scaffolds may overcome the transport ...
In this paper, we discuss the basic design requirements for the development of physiologically mean...
Generating autologous tissue grafts of a clinically useful volume requires efficient and controlled ...
AbstractTissue engineering aims to repair and regenerate damaged tissues by developing biological su...
Tissue vasculature efficiently distributes nutrients, removes metabolites, and possesses selective c...
The short shelf life along with the constant threat or an actual shortage of red blood cells (RBCs) ...